FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2489492067> ?p ?o ?g. }

• W2489492067 abstract "Abstract Background Deregulation of the DNA damage response (DDR) signaling machinery underlies genomic instability, leading to cancer development and clonal evolution. Multiple Myeloma (MM) remains an incurable disease characterized by a highly unstable genome, with aneuploidy observed in nearly all patients. The mechanism causing this karyotypic instability is largely unknown, but recent observations have correlated these abnormalities with dysfunctional DDR machinery. Mammalian NAD+-dependent deacetylase sirtuin-6 (SIRT6) is emerging as new protein involved in multiple pathways, including maintenance of genome integrity. Methods A panel of 18 MM cell lines, both sensitive and resistant to conventional and novel anti-MM therapies, was used in this study. Blood and BM samples from healthy volunteers and MM patients were obtained after informed consent and mononuclear cells (MNCs) separated by Ficoll-Paque density sedimentation. Patient MM cells were isolated from BM MNCs by CD138-positive selection. Lentiviral delivery was used for expression and knock-down of SIRT6 in MM cell lines. The biologic impact of SIRT6 phenotype was evaluated using cell growth, viability and apoptosis assays. DNA Double-Strand Breaks (DSB) repair occurring via homologous recombination (HR) or non-homologous end-joining (NHEJ) pathways was assessed using a transient direct repeat (DR)-GFP/I-SceI system. Results A comparative gene expression analysis of 414 newly-diagnosed uniformly-treated MM patients showed high levels of SIRT6 mRNA in MM patients versus MGUS or normal donors; moreover, in active MM elevated SIRT6 expression correlated with adverse clinical outcome. Due to its prognostic significance, we further evaluated its role in MM biology. We found higher SIRT6 nuclear expression in MM cell lines and primary cells compared to PBMCs from healthy donors. Targeting SIRT6 by specific shRNA increased MM cell survival by reducing DNA repair efficiency (HR and NHEJ). Whole genome profiling of three different SIRT6 knockout (Sirt6-/-) MM cell lines identified a restricted effect of SIRT6 silencing on transcription of DNA damage genes, which also represented the most down-regulated genes. Consistent with these data, GSEA algorithm revealed that gene set regulating DNA repair were prominently enriched in SIRT6 depleted cells (p<0.0001 and FDR=0.003), confirming the role of SIRT6 in this pathway. We next examined the therapeutic relevance of SIRT6 inhibition in MM by evaluating the effect of SIRT6 depletion on cytotoxicity induced by genotoxic agents. SIRT6 shRNA impaired DNA DSB repair pathways triggered by DNA damaging agents, thereby enhancing overall anti-MM activity of these agents. Finally, in concert with our in vitro data, studies using our human MM xenograft model confirmed that SIRT6 depletion enhanced anti-MM activity of DNA-damaging agents. Conclusion Collectively, our data provide basis for targeting SIRT6 as a novel therapeutic strategy in combination with genotoxic agents to enhance cytotoxicity and improve patient outcome in MM. Disclosures: Tai: Onyx: Consultancy. Hideshima:Acetylon Pharmaceuticals: Consultancy. Chauhan:Vivolux: Consultancy. Anderson:celgene: Consultancy; onyx: Consultancy; gilead: Consultancy; sanofi aventis: Consultancy; oncopep: Equity Ownership; acetylon: Equity Ownership." @default.
• W2489492067 created "2016-08-23" @default.
• W2489492067 creator A5006765393 @default.
• W2489492067 creator A5019802024 @default.
• W2489492067 creator A5019947073 @default.
• W2489492067 creator A5032464400 @default.
• W2489492067 creator A5045740077 @default.
• W2489492067 creator A5051965270 @default.
• W2489492067 creator A5062468245 @default.
• W2489492067 creator A5062694802 @default.
• W2489492067 creator A5078922292 @default.
• W2489492067 creator A5091207345 @default.
• W2489492067 date "2013-11-15" @default.
• W2489492067 modified "2023-09-27" @default.
• W2489492067 title "Role Of Sirtuin-6 In Maintenance Of Genomic Instability In Multiple Myeloma Cells" @default.
• W2489492067 doi "https://doi.org/10.1182/blood.v122.21.276.276" @default.
• W2489492067 hasPublicationYear "2013" @default.
• W2489492067 type Work @default.
• W2489492067 sameAs 2489492067 @default.
• W2489492067 citedByCount "0" @default.
• W2489492067 crossrefType "journal-article" @default.
• W2489492067 hasAuthorship W2489492067A5006765393 @default.
• W2489492067 hasAuthorship W2489492067A5019802024 @default.
• W2489492067 hasAuthorship W2489492067A5019947073 @default.
• W2489492067 hasAuthorship W2489492067A5032464400 @default.
• W2489492067 hasAuthorship W2489492067A5045740077 @default.
• W2489492067 hasAuthorship W2489492067A5051965270 @default.
• W2489492067 hasAuthorship W2489492067A5062468245 @default.
• W2489492067 hasAuthorship W2489492067A5062694802 @default.
• W2489492067 hasAuthorship W2489492067A5078922292 @default.
• W2489492067 hasAuthorship W2489492067A5091207345 @default.
• W2489492067 hasConcept C102744134 @default.
• W2489492067 hasConcept C104317684 @default.
• W2489492067 hasConcept C119157956 @default.
• W2489492067 hasConcept C134935766 @default.
• W2489492067 hasConcept C140752955 @default.
• W2489492067 hasConcept C143425029 @default.
• W2489492067 hasConcept C153911025 @default.
• W2489492067 hasConcept C178169997 @default.
• W2489492067 hasConcept C203014093 @default.
• W2489492067 hasConcept C2776364478 @default.
• W2489492067 hasConcept C2780561631 @default.
• W2489492067 hasConcept C30481170 @default.
• W2489492067 hasConcept C502942594 @default.
• W2489492067 hasConcept C54355233 @default.
• W2489492067 hasConcept C552990157 @default.
• W2489492067 hasConcept C86803240 @default.
• W2489492067 hasConceptScore W2489492067C102744134 @default.
• W2489492067 hasConceptScore W2489492067C104317684 @default.
• W2489492067 hasConceptScore W2489492067C119157956 @default.
• W2489492067 hasConceptScore W2489492067C134935766 @default.
• W2489492067 hasConceptScore W2489492067C140752955 @default.
• W2489492067 hasConceptScore W2489492067C143425029 @default.
• W2489492067 hasConceptScore W2489492067C153911025 @default.
• W2489492067 hasConceptScore W2489492067C178169997 @default.
• W2489492067 hasConceptScore W2489492067C203014093 @default.
• W2489492067 hasConceptScore W2489492067C2776364478 @default.
• W2489492067 hasConceptScore W2489492067C2780561631 @default.
• W2489492067 hasConceptScore W2489492067C30481170 @default.
• W2489492067 hasConceptScore W2489492067C502942594 @default.
• W2489492067 hasConceptScore W2489492067C54355233 @default.
• W2489492067 hasConceptScore W2489492067C552990157 @default.
• W2489492067 hasConceptScore W2489492067C86803240 @default.
• W2489492067 hasLocation W24894920671 @default.
• W2489492067 hasOpenAccess W2489492067 @default.
• W2489492067 hasPrimaryLocation W24894920671 @default.
• W2489492067 hasRelatedWork W2012614358 @default.
• W2489492067 hasRelatedWork W2129131491 @default.
• W2489492067 hasRelatedWork W2145637287 @default.
• W2489492067 hasRelatedWork W2153105560 @default.
• W2489492067 hasRelatedWork W2267892621 @default.
• W2489492067 hasRelatedWork W2554059528 @default.
• W2489492067 hasRelatedWork W2735780224 @default.
• W2489492067 hasRelatedWork W2796456052 @default.
• W2489492067 hasRelatedWork W2811282511 @default.
• W2489492067 hasRelatedWork W2892020498 @default.
• W2489492067 hasRelatedWork W2898225638 @default.
• W2489492067 hasRelatedWork W2905103072 @default.
• W2489492067 hasRelatedWork W2906108460 @default.
• W2489492067 hasRelatedWork W2955344382 @default.
• W2489492067 hasRelatedWork W2969351441 @default.
• W2489492067 hasRelatedWork W2971118157 @default.
• W2489492067 hasRelatedWork W2982329803 @default.
• W2489492067 hasRelatedWork W3123309940 @default.
• W2489492067 hasRelatedWork W3133588220 @default.
• W2489492067 hasRelatedWork W3137208392 @default.
• W2489492067 isParatext "false" @default.
• W2489492067 isRetracted "false" @default.
• W2489492067 magId "2489492067" @default.
• W2489492067 workType "article" @default.